OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Ryan Lim

1 Projects | 1 Researchers | $4,845,794 Invested

2024

Modulo Bio, Inc.

Ryan Lim, PhD

Development of a novel, highly brain penetrant CSF1R inhibitor for the treatment of FTD, ALS, AD and related dementias.

  • Funding Amount: $4,845,794
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Target: Inflammation
  • Status: Active